|
USP48 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.24418311395902E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.55429957372189E-10 |
| Normal-vs-Stage2 |
1.57251999999275E-05 |
| Normal-vs-Stage3 |
7.60469465177493E-11 |
| Normal-vs-Stage4 |
4.43230008251305E-10 |
| Stage1-vs-Stage2 |
9.763600E-01 |
| Stage1-vs-Stage3 |
8.273500E-02 |
| Stage1-vs-Stage4 |
4.678200E-02 |
| Stage2-vs-Stage3 |
2.625200E-01 |
| Stage2-vs-Stage4 |
1.774960E-01 |
| Stage3-vs-Stage4 |
7.153600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70885527950304E-12 |
| Normal-vs-AfricanAmerican |
2.441800E-02 |
| Normal-vs-Asian |
3.55640000004875E-07 |
| Caucasian-vs-AfricanAmerican |
2.078000E-02 |
| Caucasian-vs-Asian |
6.591800E-01 |
| AfricanAmerican-vs-Asian |
7.699500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22050003437124E-09 |
| Normal-vs-Female |
3.34270389146241E-11 |
| Male-vs-Female |
9.759800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8911000543298E-09 |
| Normal-vs-Age(41-60Yrs) |
1.47830003793814E-09 |
| Normal-vs-Age(61-80Yrs) |
7.66270047414253E-10 |
| Normal-vs-Age(81-100Yrs) |
5.980400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.526600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.411200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.049600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.958800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.940800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.109600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.283300E-03 |
| Classical-VS-Follicular |
7.368000E-01 |
| Classical-VS-Other |
2.953600E-01 |
| Classical-VS-Normal |
1.58349999779261E-10 |
| Tall-VS-Follicular |
1.029960E-02 |
| Tall-VS-Other |
5.507800E-01 |
| Tall-VS-Normal |
2.08399963952388E-11 |
| Follicular-VS-Other |
5.009000E-01 |
| Follicular-VS-Normal |
2.47689999999245E-06 |
| Other-VS-Normal |
1.537170E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.39350033920994E-10 |
| Normal-vs-N1 |
1.06240016783943E-10 |
| N0-vs-N1 |
1.131230E-01 |
|
|
